X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet   (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 382.7
Mkt Cap Rs m 920,944
Vol '000 294.0
P/E X 28.9
P/CF X 22.3
EPS (TTM) Rs 13.2
% ch % -2.5
No. of shares m 2,406.75
% ch week % -4.8
% ch 1-mth % -6.2
% ch 12-mth % -33.0
52 week H/L Rs 678.8/350.4
(As on Jun 17, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs6531,0741,201842701 
Low Rs493570706572433 
Sales per share (Unadj.) Rs77.6132.3118.4131.6110.4 
Earnings per share (Unadj.) Rs15.221.923.532.711.0 
Diluted earnings per shareRs13.118.923.532.610.9 
Cash flow per share (Unadj.) Rs17.127.727.837.917.2 
Dividends per share (Unadj.) Rs1.503.001.003.502.00 
Adj. dividends per shareRs1.292.581.003.491.99 
Dividend yield (eoy) %0.30.40.10.50.4 
Book value per share (Unadj.) Rs89.4135.2137.1152.7158.8 
Adj. book value per shareRs77.0116.4137.0152.2158.3 
Shares outstanding (eoy) m2,071.162,071.162,406.602,399.262,399.26 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x7.46.28.15.45.1 
Avg P/E ratio x37.837.540.621.751.6 
P/CF ratio (eoy) x33.429.734.318.632.9 
Price / Book Value ratio x6.46.17.04.63.6 
Dividend payout %9.913.74.310.718.2 
Avg Mkt Cap Rs m1,186,7751,703,0112,294,8131,696,8771,360,021 
No. of employees `00014.0NA14.717.517.8 
Total wages/salary Rs m20,74445,02647,72349,02353,671 
Avg. sales/employee Rs Th11,486.0NM19,317.218,028.314,890.9 
Avg. wages/employee Rs Th1,481.7NM3,236.12,798.83,017.1 
Avg. net profit/employee Rs Th2,243.9NM3,836.94,473.81,480.6 
SUN PHARMA INCOME DATA
Net Sales Rs m160,804273,920284,870315,784264,895 
Other income Rs m2,6475,4776,5836,2328,388 
Total revenues Rs m163,451279,397291,453322,016273,282 
Gross profit Rs m72,87378,66781,583100,89356,081 
Depreciation Rs m4,09211,94710,37512,64814,998 
Interest Rs m4425,7905,2323,9985,176 
Profit before tax Rs m70,98666,40772,55890,47944,295 
Minority Interest Rs m-7,375-9,363000 
Prior Period Items Rs m0-1261500 
Extraordinary Inc (Exp) Rs m-25,174-2,378-6,8520-9,505 
Tax Rs m7,0229,1479,13812,1168,452 
Profit after tax Rs m31,41545,39456,58378,36326,338 
Gross profit margin %45.328.728.631.921.2 
Effective tax rate %9.913.812.613.419.1 
Net profit margin %19.516.619.924.89.9 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m186,865288,782299,413329,537316,359 
Current liabilities Rs m59,896153,294131,440178,870198,643 
Net working cap to sales %79.049.559.047.744.4 
Current ratio x3.11.92.31.81.6 
Inventory Days Days7176827995 
Debtors Days Days50688783108 
Net fixed assets Rs m58,242151,694180,477204,766213,178 
Share capital Rs m2,0712,0712,4072,3992,399 
"Free" reserves Rs m163,019278,009327,418363,997378,606 
Net worth Rs m185,250280,080329,825366,397381,006 
Long term debt Rs m48713,59831,10314,36117,721 
Total assets Rs m293,708501,601555,303614,102643,028 
Interest coverage x161.612.514.923.69.6 
Debt to equity ratio x000.100 
Sales to assets ratio x0.50.50.50.50.4 
Return on assets %10.810.211.113.44.9 
Return on equity %17.016.217.221.46.9 
Return on capital %20.920.519.724.810.0 
Exports to sales %14.116.913.900 
Imports to sales %3.64.53.100 
Exports (fob) Rs m22,71346,23539,57200 
Imports (cif) Rs m5,77912,2298,88200 
Fx inflow Rs m23,16848,70642,17144,11840,816 
Fx outflow Rs m12,62925,56421,58324,48430,143 
Net fx Rs m10,53923,14220,58819,63410,673 
SUN PHARMA CASH FLOW
From Operations Rs m 39,592 56,157 66,859 70,822 39,072 
From Investments Rs m -23,668 -28,657 -43,716 -42,216 -33,708 
From Financial Activity Rs m 5,066 -11,865 -18,885 -22,854 -15,393 
Net Cashflow Rs m 20,990 15,635 8,482 6,107 -7,359 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.5

Read: SUN PHARMA 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   VENUS REMEDIES  STRIDES PHARMA SCIENCE  NATCO PHARMA  AJANTA PHARMA  SHASUN PHARMA  

Compare SUN PHARMA With:   VENUS REMEDIES  STRIDES PHARMA SCIENCE  NATCO PHARMA  AJANTA PHARMA  SHASUN PHARMA  

Compare SUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 491 Points Lower; Metal and Energy Stocks Witness Selling(Closing)

After opening the day marginally lower, share markets in India witnessed negative trading activity throughout the day and ended deep in the red.

Views on news

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

FM Nirmala Sitharaman Inherits an Economy Facing a Number of Headwinds(Sector Info)

Jun 4, 2019

The Indian economy is in a major slowdown. Will the new finance minister, Nirmala Sitharaman bring the much-needed reforms?

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - UNICHEM LAB COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS